Importantly, we show that CSF filtration and targeted depletion of ApoB from sALS CSF prevents the induction of motor deficits and motor neuron degeneration, thus providing a novel therapeutic target and therapeutic approach to alleviate disease pathophysiology in the predominant sporadic form of ALS. The gene discussed is APOB; the disease is amyotrophic lateral sclerosis.